Autopsy report · NCT04537013

Clinical Study of Chondro-Gide® for Large Chondral Lesions in the Knee

“The study was terminated early due to a change in business strategy at the sponsor, unrelated to any safety concerns with the medical device.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 5 years 1 month before it stopped.
• 82 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Geistlich Pharma AG

Sponsor type

Industry

Conditions

Knee Injuries; Cartilage Injury; Cartilage Disease; Knee Discomfort

Interventions

Microfracture; Microfracture plus placement of Chondro-Gide® ACC

Participants

82

Sites

15

Countries

Canada, Germany, United States

Trials that died the same way

• Study of Secukinumab in Patients With Newly-diagnosed Type 1 Diabetes Mellitus
  “This study was terminated prematurely by the Sponsor for business reasons only.” (82% match in meaning)
• A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients
  “The study has been early terminated due to business reasons. This decision is not related to any safety, efficacy, or regulatory concerns.” (80% match in meaning)
• An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
  “The study was terminated early due to sponsor decision unrelated to safety or efficacy findings” (80% match in meaning)
• Study of Ataluren (PTC124) in Hemophilia A and B
  “Study was terminated early due to Sponsor decision and not reflective of adverse safety findings.” (80% match in meaning)
• A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome
  “The study was terminated by Sponsor and the decision was not due to any safety or efficacy reasons.” (80% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.